Fujian Aonong Biological Technology Group Incorporation Balans Gezondheid
Financiële gezondheid criteriumcontroles 2/6
Fujian Aonong Biological Technology Group Incorporation has a total shareholder equity of CN¥-1.4B and total debt of CN¥6.8B, which brings its debt-to-equity ratio to -469.7%. Its total assets and total liabilities are CN¥11.8B and CN¥13.3B respectively.
Belangrijke informatie
-469.7%
Verhouding schuld/eigen vermogen
CN¥6.81b
Schuld
| Rente dekkingsratio | n/a |
| Contant | CN¥382.19m |
| Aandelen | -CN¥1.45b |
| Totaal verplichtingen | CN¥13.26b |
| Totaal activa | CN¥11.81b |
Recente financiële gezondheidsupdates
Geen updates
Analyse van de financiële positie
Kortlopende schulden: 603363 has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.
Langlopende schulden: 603363 has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: 603363 has negative shareholder equity, which is a more serious situation than a high debt level.
Schuld verminderen: 603363's has negative shareholder equity, so we do not need to check if its debt has reduced over time.
Balans
Analyse van de cashflow
Voor bedrijven die in het verleden gemiddeld verliesgevend zijn geweest, beoordelen we of ze ten minste 1 jaar kasstroom hebben.
Stabiele cash runway: Whilst unprofitable 603363 has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.
Voorspelling contante baan: 603363 is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 15.6% per year.